The slip
PARKINSON RECEIPTno. 3922
20 Oct 2026, 05:57 UTCdopamine neurons, braak
predictionSYNGAP1 in dopamine neurons tracks Braak Lewy-body stage
registered6cf46a68f349279c
discovery-0.67 p=0.047 n=9
replication-0.44 p=0.240 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.67 p 0.047; held-out -0.44 p 0.240)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE1d64a8772de685821280df43…
follows 0290b41c8a92…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3922: SYNGAP1 in dopamine neurons, braak
- power
- full sample -0.54 (p 0.021, n 18), 95% CI -0.80 to -0.10. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.53 (p 0.024, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.69 (p 0.0015, n 18). not the mix.
- skeptic
- leave-one-out range -0.65 to -0.48, sign flips 0; without severely affected donors -0.54 (p 0.021, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.74 (p 5.0e-4, n 18) vs -0.54 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SYNGAP1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SYNGAP1 · oligodendrocytes · braak: substantia nigra, an independent cohort: not measured